CORCEPT THERAPEUTICS INC
For the period ended Jun 30, 2024. Filed Jul 29, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 29, 2024
CORT$73.35-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net income | 35,488 | 27,528 | 63,250 | 43,407 |
| Other comprehensive income (loss): | ||||
| Unrealized (loss) gain on available-for-sale investments, net of tax effect of $14, $(23), $117 and $(215), respectively | (189) | 75 | (519) | 680 |
| Foreign currency translation gain (loss), net of tax | 15 | 123 | (6) | 234 |
| Total comprehensive income | $35,314 | $27,726 | $62,725 | $44,321 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.